|
Book Detail
 |
Clinical Manual of Child and Adolescent Psychopharmacology
Findling, Robert L., Ed.
|
Category: Psychopharmacology Publisher: American Psychiatric Press, Inc. Affiliation: Case Western Reserve University; Cleveland, OH Dimensions: 8.2 x 1.0 x 5.4 in
|
|
|
|
Synopsis:
In a rapidly changing and often controversial field, this book is designed to meet the needs of clinicians who want to provide state-of-the-art care to younger patients with psychiatric disorders. Clinical Manual of Child and Adolescent Psychopharmacology is a succinct and practical guide, written by expert authorities with both clinical and research expertise, containing a wealth of both evidence-based and scientifically sound information. It enables practitioners to more effectively address commonly-seen disorders such as attention-deficit/hyperactivity disorder (ADHD), gain new insight into high-profile problems like juvenile suicide, and become better informed regarding conditions, such as anxiety disorders, that frequently go undiagnosed and untreated only to result in life-long impairments. The text first reviews developmental aspects of pediatric psychopharmacology, explaining why children and adolescents don't always respond to psychopharmacological treatment the same way as adults, and exploring issues pertaining to the safety and efficacy of treatment. It then moves on to specific chapters covering problems that practitioners find most vexing, from ADHD to pediatric major depressive disorder to juvenile-onset schizophrenia. It also discusses pharmacotherapy for youths who are primarily seen in general medical settings, covering such conditions as functional somatic syndromes and somatoform disorders, eating disorders, sleep disorders, elimination disorders, and delirium. Among the book's key features: * Reviews the use of both stimulant and nonstimulant agents for attention-deficit/hyperactivity disorder, considering key aspects regarding the implementation and monitoring of patients. * Provides recommendations regarding pharmacological approaches to disruptive behavior disorders (DBDs), stressing an understanding of aggression across the DBD spectrum. * Considers potential benefits and risks of medications for anx
|
|
|
|
|
|
|